Zim Laboratories has completed the process of investment of Euro 3,00,000 in the equity shares of SIA ZIM Laboratories. Post investment, the shareholding of the company remains at 100% of the total share capital of SIA ZIM Laboratories.
Earlier, the board of directors of the company in their meeting held on March 28, 2025 had approved the investment in SIA ZIM Laboratories, wholly owned subsidiary of the company.
ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develop generic pharmaceutical products.
